3 top FTSE 100 shares I’d buy in July

These FTSE 100 shares should perform well in the future despite today’s uncertain outlook, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Should you be buying shares when the economic outlook is so uncertain? Absolutely! I’ve found a number of FTSE 100 shares that I think will deliver strong returns to long-term investors from current levels.

Healthcare heavyweight

If you’re building a diversified, long-term portfolio, I think you need to have some exposure to the healthcare sector. It’s an essential global business for which I believe demand will only grow.

My top FTSE 100 pick in this sector is pharmaceutical giant GlaxoSmithKline (LSE: GSK). Alongside its prescription medicine and vaccine businesses, the group also has a large consumer healthcare business — home to brands such as Sensodyne and Nicorette.

Glaxo plans to seperate its consumer business into a new company over the next couple of years. This will dividen the group into two smaller and more focused businesses. I think this will improve their growth potential — good news for shareholders.

The GSK share price has now fallen by nearly 15% from the highs seen earlier this year. The shares now trade on about 13.5 times forecast earnings, with a 5% dividend yield. I think this FTSE 100 share is priced to buy.

A FTSE 100 share for tech investors

Big tech stocks are rare in the UK. One exception is cyber security software group Avast (LSE: AVST). This Prague-based firm only floated on the London market in 2018, but its continued growth has already lifted it into the FTSE 100. I think there could be more to come.

Avast’s core anti-virus product has a free version, which the firm uses to recruit users to whom it can sell additional services. The group also has a corporate business. This might sound like a small operation but it’s not — Avast has over 435m active users and generated revenue of $873m in 2019.

Operating profit margins are high, at around 40%. Cash generation is good too, which means the group’s after-tax profits are reliably converted into spare cash. The only criticism I’d make is that the firm’s growth rate is relatively low — adjusted profits rose by just 8% last year.

Despite this, I think Avast’s strong financial performance and large customer base should support continued growth. The shares currently trade on about 20 times forecast earnings, with a dividend yield of around 2.1%. I think that’s a fair price to pay for this high quality FTSE 100 share.

A fashion stock you can trust

When you invest in a company there’s always an element of risk. As outsiders we never know everything about a business. One company that tries hard to provide a level playing field is retailer Next (LSE: NXT), which is known for the quality of its financial reporting.

The bad news is that Next’s management expect sales to fall by between 30% and 40% this year. As a result, pre-tax profits are expected to fall from £728m last year to a maximum of £150m.

However, there’s good news too. Careful management means that the group’s financial position remains very strong. Net debt is actually expected to fall this year.

Another attraction is that broker forecasts suggest profits will bounce back quickly next year. If they’re correct, then this FTSE 100 share now trades on just 13 times forecast earnings.

Next is a highly profitable business with an excellent track record of shareholder returns. I’d rate the shares as a buy at this level.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Next. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

If I’d invested £1,000 before the IAG share price collapsed, here’s what I’d have now

The IAG share price has been resurgent in recent months with a near-index-topping 17.9% growth since the beginning of the…

Read more »

Investing Articles

2 reliable growth stocks I’d consider for a new Stocks and Shares ISA in 2024

There's still lots of time to pack that Stocks and Shares ISA with all the best mid-cap UK growth stocks…

Read more »

British bank notes and coins
Investing Articles

2 dirt cheap FTSE 100 stocks I’d buy in May

These FTSE 100 stocks still look undervalued despite the index's recent bull run. Here's why I'd buy them for my…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Looking for FTSE 100 and FTSE 250 bargains? Here’s one of the best!

Deciding on the FTSE's greatest value stock is a subjective thing. But based on current forecasts, I think ITV is…

Read more »

Top Stocks

5 stocks that Fools have recently sold

Three complete exits and one partial sale of a shareholding -- why did these five Fools sell these particular UK-listed…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Growth Shares

2 growth shares that could help push the FTSE 100 to 9,000 points this year

Jon Smith flags up the surge in the FTSE 100 and outlines two growth shares that he feels could help…

Read more »

Young female analyst working at her desk in the office
Investing Articles

Airtel Africa’s share price sinks on profits hit! Time to buy?

Airtel Africa's share price has plunged as news of currency devaluations spook investors. Is this a great dip buying opportunity?

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

What are the best AI stocks to buy for explosive growth potential?

Oliver Rodzianko thinks there are many great AI stocks to buy, even after all the hype. He believes robotics could…

Read more »